HIGHMARK, INC. for HIGHMARK INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
HR3920 "Trade and Globalization Act of 2007" and S1848 "TAA Health Coverage Improvement Act of 2007" - parts pertaining to the Health Coverage Tax Credit; HM e-prescribing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Health Issues HCR
See attached addendum for General Lobbying Issue Area: HCR - Healthcare Antitrust and Health Insurance Reform: HR971 and S2161 "Community Pharmacy Fairness Act of 2007", S618 "Insurance Industry Competition Act of 2007" Health Information Technology Standards; Electronic Health Records; ICD10 Implementation: HR1368 "Personalized Health Information Act of 2007"; S1783 and S1693 "Wired for Health Care Quality Act"; HR3800 "Promoting Health Information Technology Act"; HR2406 "Healthcare Information Technology Enterprise Integration Act", HR6357 "Pro(Tech)t Act of 2008" Healthcare Reform; Insurance Market Reform; Employer Based Healthcare System; Small Group Market/Small Business Healthcare; Uninsured: S1019 "Health Care Choice Act of 2007"; S334 and HR3163 "Healthy Americans Act"; S2795 "Small Business Health Options Program Act of 2008" Genetic Non-discrimination: HR493 and S358 "Genetic Information Nondiscrimination Act of 2007" Mental Health Parity: HR1424 "Paul Wellstone Mental Health and Addiction Equity Act of 2007" and S558 "Mental Health Parity Act of 2007" TAA; HR3801 and S1848 "TAA Health Coverage Improvement Act of 2007" Comparative Effectiveness Reseaarch: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act" Health Savings Accounts/Medical Savings Accounts; SCHIP S2041 "False Claim Act Correction of 2007" as it pertains to the payment of healthcare claims.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Pharmacy PHA
E-prescribing; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act."
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Medicare/Medicaid MMM
Medicare; Medicare Part D; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"; Medicare Electronic Health Records; Pay for Performance; Medicare Advantage: HR 6331 "Medicare Improvements for Patients and Providers Act of 2008"; S3101 "Medicare Improvements for Patients and Providers Act of 2008"; S3118 "Preserving Access to Medicare Act of 2008."
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Budget/Appropriations BUD
Medicare Advantage Funding: HR 6331 "Medicare Improvements for Patients and Providers Act of 2008"; S3101 "Medicare Improvements for Patients and Providers Act of 2008"; S3118 "Preserving Access to Medicare Act of 2008"; and Comparative Effectiveness Funding: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act."
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.